Home › Funds › D. E. Shaw & Co › PCRX
D. E. Shaw & Co position in PCRX
PACIRA BIOSCIENCES INC · Health Care
Latest position (Q2 2026)1.95M sh
Reported value held$49.48M
Portfolio Weight0.03%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 79.73K | $4.46M | New |
| Q4 2021 | 49.70K | $2.99M | Reduce |
| Q1 2022 | 11.65K | $889.00K | Reduce |
| Q1 2023 | 19.03K | $776.70K | New |
| Q2 2023 | 5.31K | $212.73K | Reduce |
| Q3 2023 | 157.06K | $4.82M | Add |
| Q4 2023 | 206.02K | $6.95M | Add |
| Q1 2024 | 240.44K | $7.03M | Add |
| Q2 2024 | 5.15M | $4.85M | Add |
| Q3 2024 | 7.65M | $7.33M | Add |
| Q4 2024 | 7.65M | $7.40M | Hold |
| Q1 2025 | 7.65M | $7.55M | Hold |
| Q2 2025 | 6.00M | $5.87M | Reduce |
| Q3 2025 | 6.00M | $6.09M | Hold |
| Q4 2025 | 2.04M | $52.79M | Reduce |
| Q1 2026 | 1.98M | $44.81M | Reduce |
| Q2 2026 | 1.95M | $49.48M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PCRX
- Vanguard Group 4.81M sh · $124.56M · Q4 2025
- Renaissance Technologies 1.73M sh · $43.99M · Q2 2026
- Goldman Sachs Group 1.53M sh · $38.74M · Q2 2026
- Geode Capital Management 1.16M sh · $29.40M · Q2 2026
- Morgan Stanley 1.14M sh · $29.04M · Q2 2026
- UBS Group AG 920.22K sh · $23.35M · Q2 2026
- Two Sigma Investments 724.60K sh · $18.38M · Q2 2026
- Charles Schwab Investment Management 690.79K sh · $17.53M · Q2 2026
- Wellington Management Group 563.46K sh · $14.29M · Q2 2026
- Northern Trust Corp 526.78K sh · $13.36M · Q2 2026
- BNY Mellon 296.88K sh · $7.53M · Q2 2026